Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa

被引:19
|
作者
Farley, Jason E. [1 ]
Kelly, Ana M. [2 ]
Reiser, Katrina [1 ]
Brown, Maria [1 ]
Kub, Joan [1 ,3 ]
Davis, Jeane G. [1 ]
Walshe, Louise [3 ]
Van der Walt, Martie [4 ]
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
[2] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] MRC, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa
来源
PLOS ONE | 2014年 / 9卷 / 11期
基金
美国国家卫生研究院;
关键词
XDR-TB; GUIDELINES; INFECTION; EPIDEMIC; CARE;
D O I
10.1371/journal.pone.0111702
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Setting: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. Objective: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection. Design: A quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period. Results: The greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement). Conclusion: Improvements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
    Al-Mutairi, Noura M.
    Ahmad, Suhail
    Mokaddas, Eiman M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2019, 24 (01)
  • [42] Outcome of multidrug-resistant tuberculosis (MDR-TB): A comparison between inpatient and outpatient therapy.
    Alonso, P
    Narita, M
    Lausardo, M
    Hollender, E
    Ashkin, D
    Pitchenik, AE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A551 - A551
  • [43] Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
    Ateba-Ngoa, U.
    Edoa, J. R.
    Adegbite, B. R.
    Rossatanga, E. G.
    Madiou, D.
    Mfoumbi, A.
    Mevyann, C.
    Agbo, P. Achimi
    Mahoumbou, J.
    Gould, S.
    Lell, B.
    Adegnika, A. A.
    Koehler, C.
    Kremsner, P. G.
    Massinga-Loembe, M.
    Alabi, A.
    Grobusch, M. P.
    INFECTION, 2019, 47 (05) : 811 - 816
  • [44] The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
    Brigaste M.B.T.
    Teh L.A.
    Psychological Studies, 2018, 63 (1) : 9 - 18
  • [45] Acute Respiratory Failure and Sepsis Due to Multidrug-Resistant Tuberculosis (MDR-TB) in a Pregnant Midwife
    Colunche, C.
    Angeles, B.
    Maguina, M.
    Yachachin, J.
    Chavez, W.
    Diaz, J.
    Accinelli, R.
    Valdivia, E.
    Tafur, K.
    Morello, E.
    Chancafe, R.
    Cok, J.
    Lovaton, N.
    Gayoso, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
    Noura M. Al-Mutairi
    Suhail Ahmad
    Eiman M. Mokaddas
    European Journal of Medical Research, 24
  • [47] Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
    Sturdy, Ann
    Goodman, Anna
    Jose, Ricardo J.
    Loyse, Angela
    O'Donoghue, Marie
    Kon, Onn Min
    Dedicoat, Martin J.
    Harrison, Thomas S.
    John, Laurence
    Lipman, Marc
    Cooke, Graham S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1815 - 1820
  • [48] Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
    U. Ateba-Ngoa
    J. R. Edoa
    B. R. Adegbite
    E. G. Rossatanga
    D. Madiou
    A. Mfoumbi
    C. Mevyann
    P. Achimi Agbo
    J. Mahoumbou
    S. Gould
    B. Lell
    A. A. Adegnika
    C. Köhler
    P. G. Kremsner
    M. Massinga-Loembe
    A. Alabi
    M. P. Grobusch
    Infection, 2019, 47 : 811 - 816
  • [49] Stigma in People With Multidrug-resistant Tuberculosis and HIV in South Africa
    Reis, K.
    Wolf, A.
    Perumal, R.
    Zulu, M.
    Seepamore, B.
    Guzman, K. J.
    Ross, J. E.
    Nyilana, H.
    Cheung, Y. K.
    Friedland, G.
    Naidoo, K.
    Zelnick, J.
    Daftary, A.
    O'Donnell, M. R.
    Amico, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [50] In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates
    Prammananan, Therdsak
    Chaiprasert, Angkana
    Leechawengwongs, Manoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (02) : 190 - 191